IOP-independent treatment for neurodegeneration in glaucoma using optimized ROS-scavenging microparticles for sustained release of erythropoietin
Carlisle R. DeJulius, Sarah A. Naguib, Patricia L. Poley, Marselle A. Rasdall, Thomas Dean, Amy N. Conner, Sariah D'Empaire-Salomon, Rachel Hardin, Elisabeth Artis, Richard d’Arcy, Brian Carlson, David John Calkins, Craig L. Duvall, Tonia S. Rex
This paper develops ROS-scavenging microparticles for sustained EPO release to treat glaucoma neurodegeneration, showing neuron preservation in animal models.
bioRxiv · Oct 30, 2026 · PreprintBioengineering